MTPConnect has opened a call for Expressions of Interest to identify and select a number of biological and medical technology innovation initiatives that address one of the following four priority therapeutic areas:
Emergency medicine/trauma; or
Up to $1 million of funding is offered for individual projects over a two-year period, that address one of more of nine speicifc clinical challenges these four therapeutic areas.
The BioMedTech Horizons Program was one of the commitments delivered as part of the Medical Technology Association of Australia’s (MTAA) 2017 Agreement with the Commonwealth to promote the sustainability of privately insured health care through rebalancing the costs of medical devices to privately insured patients.
This funding is being delivered via the Medical Research Future Fund (MRFF), and administered by MTPConnect, the Medical Technology and Pharmaceutical Industry Growth Centre.
Investments from the program will be focused on funding proof-of-concept to commercial development of biomedical and medical technologies (biomedtech).